Latest Respiratory syncytial virus News
Moderna lays out plan to slice research and development spending
Shares of Moderna tumbled early Thursday after the vaccine developer said it was cutting research and development spending and pushed back its time frame for breaking even. The company also forecast a 2025 revenue range that fell below Wall Street expectations. Moderna...
US health officials strengthen endorsement of RSV shots for oldest Americans
NEW YORK (AP) — U.S. health officials on Wednesday made a stronger endorsement for RSV vaccinations for people 75 and older, but offered a narrower recommendation for people 60 to 74. The director of the Centers for Disease Control and Prevention accepted the recommendations from a...
LOADING MORE STORIES
